BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2349087)

  • 1. Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents.
    Iyer RP; Uznanski B; Boal J; Storm C; Egan W; Matsukura M; Broder S; Zon G; Wilk A; Koziolkiewicz M
    Nucleic Acids Res; 1990 May; 18(10):2855-9. PubMed ID: 2349087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of alpha-anomeric homopyrimidine oligo DNA phosphorothioates and their physicochemical and biochemical properties.
    Shinozuka K; Yamada N; Sawai H
    Nucleic Acids Symp Ser; 1995; (34):121-2. PubMed ID: 8841582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
    Matsukura M; Zon G; Shinozuka K; Stein CA; Mitsuya H; Cohen JS; Broder S
    Gene; 1988 Dec; 72(1-2):343-7. PubMed ID: 3243433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus.
    Kim SG; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1614-9. PubMed ID: 1930201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
    Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
    Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of stereoregulated oligodeoxyribonucleoside phosphorothioates.
    Oka N; Yamamoto M; Sato T; Wada T
    Nucleic Acids Symp Ser (Oxf); 2006; (50):123-4. PubMed ID: 17150848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
    Matsukura M; Shinozuka K; Zon G; Mitsuya H; Reitz M; Cohen JS; Broder S
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7706-10. PubMed ID: 3499613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
    Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1.
    Farooqui F; Sarin PS; Sun D; Letsinger RL
    Bioconjug Chem; 1991; 2(6):422-6. PubMed ID: 1805939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.
    Stein CA; Neckers LM; Nair BC; Mumbauer S; Hoke G; Pal R
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):686-93. PubMed ID: 1711118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.
    Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis of nucleoside 5'-O-(1,1-dithiotriphosphates).
    Okruszek A; Olesiak M; Balzarini J
    J Med Chem; 1994 Oct; 37(22):3850-4. PubMed ID: 7525960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-HIV activity of oligoribonucleotides and their phosphorothioate analogs.
    Agrawal S; Tang JY; Sun D; Sarin PS; Zamecnik PC
    Ann N Y Acad Sci; 1992 Oct; 660():2-10. PubMed ID: 1340121
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.
    Siddiqui MA; Driscoll JS; Marquez VE; Roth JS; Shirasaka T; Mitsuya H; Barchi JJ; Kelley JA
    J Med Chem; 1992 Jun; 35(12):2195-201. PubMed ID: 1351945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and properties of modified oligonucleotides.
    Letsinger RL; Alul RA; Farooqui F; Gryaznov SM; Kinstler O
    Nucleic Acids Symp Ser; 1991; (24):75-8. PubMed ID: 1841386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T; Sakata T; Kaji A; Kaji H
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles.
    Chimirri A; Grasso S; Monforte AM; Monforte P; Zappala M
    Farmaco; 1991; 46(7-8):925-33. PubMed ID: 1686551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of d(GC) and d(CG) octamers containing alternating phosphorothioate linkages: effect of the phosphorothioate group on the B-Z transition.
    Cosstick R; Eckstein F
    Biochemistry; 1985 Jul; 24(14):3630-8. PubMed ID: 4041432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.
    Leiter JM; Agrawal S; Palese P; Zamecnik PC
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3430-4. PubMed ID: 2333292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.